COVID-19: consider cytokine storm syndromes and immunosuppression
COVID-19: consider cytokine storm syndromes and immunosuppression
COVID-19: consider cytokine storm syndromes and immunosuppression
We describe a patient in Wuhan, China, with severe acute respiratory syndrome coronavirus 2 infection who had progressive pulmonary lesions and rhabdomyolysis with manifestations of lower limb pain and fatigue. Rapid clinical recognition...
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare.
COVID-19 and the liver: little cause for concern
WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). The number of patients with COVID-19...
COVID-19 is a coronavirus outbreak that initially appeared in Wuhan, Hubei Province, China, in December 2019, but it has already evolved into a pandemic spreading rapidly worldwide<sup>,</sup>. As of 18 March 2020, a total number of 194909...
Sixty seconds on . . . anosmia
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia
Leukoerythroblastic reaction in a patient with COVID-19 infection
Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive